The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma

Clinical and Experimental Allergy

Volumn 35, Issue 2, 2005, Pages 213-220

  Stelmach, I ^a   Majak, P ^a   Jerzynska, J ^a   Kuna, P ^b  

^a M Curie Hospital   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Childhood asthma; IL 10; Montelukast

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; HOUSE DUST ALLERGEN; INTERLEUKIN 10; MONTELUKAST; POLLEN ANTIGEN; SALBUTAMOL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HOUSE DUST ALLERGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MONONUCLEAR CELL; PHLEUM PRATENSE; POLLEN ALLERGY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACETATES; ADOLESCENT; ANALYSIS OF VARIANCE; ASTHMA; CHILD; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-10; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; LEUKOTRIENE ANTAGONISTS; LUNG; MALE; QUINOLINES; SEASONS; TREATMENT OUTCOME;

EID: 14844346527     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02154.x     Document Type: Article

References (31)

1. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S. Interleukin-10 regulation in normal and asthmatic subjects. J Allergy Clin Immunol 1996; 97:1288-96.
2. Bullens DM, Van Den Keybus C, Dilissen E, Kasran A, Ceuppens JL. Allergen-specific T cells from birch-pollen-allergic patients and healthy controls differ in T helper 2 cytokine and in interleukin-10 production. Clin Exp Allergy 2004; 34:879-87.
3. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy - review of a new approach. Pharmacol Rev 2003; 55:241-69.
4. Borish L. IL-10 evolving concepts. J Allergy Clin Immunol 1998; 101:293-7.
5. Akdis CA, Joss A, Akdis M, Faith A, Blaser K. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J 2000; 14: 1666-8. (No abstract available. Erratum in: FASEB J 2000; Oct 14(13):2128).
6. Akdis CA, Joss A, Akdis M, Faith A, Blaser K. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J 2000; 14: 1666-8. (No abstract available. Erratum in: FASEB J 2000; Oct 14(13):2128).
7. Savolainen J, Laaksonen K, Rantio-Lehtimaki A, Terho EO. Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy. Clin Exp Allergy 2004; 34:413-9.
8. Schandene L, Alonso Vega C, Willems F et al. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol 1994; 152:4368-74.
9. Ohkawara Y, Lim KG, Xing Z et al. CD40 expression by human peripheral blood eosinophils. J Clin Invest 1996; 97:1761-6.
10. Contreras JP, Ly NP, Gold DR et al. Allergen-induced cytokine production, atopic disease, IgE, and wheeze in children. J Allergy Clin Immunol 2003; 112:1072-7.
11. Tillie-Leblond I, Pugin J, Marquette CH et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999; 159:487-94.
12. Makela MJ, Kanehiro A, Borish L et al. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci USA 2000; 97:6007-1.
13. Yang X, Wang S, Fan Y, Han X. IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction. Eur J Immunol 2000; 30:382-91.
14. Macaubas C, Sly PD, Burton P et al. Regulation of T-helper cell responses to inhalant allergen during early childhood. Clin Exp Allergy 1999; 29:1223-31.
15. Jutel M, Akdis M, Budak F et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33:1205-14.
16. Francis JN, Till SJ, Durham SR. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003; 111:1255-61.
17. Stelmach I, Jerzyńska J, Kuna P. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. Clin Exp Allergy 2002; 32:264-9.
18. National Asthma Education and Prevention Program., Expert panel report 2: guidelines for the diagnosis and management of asthma. NIH/National Heart, Lung, and Blood Institute, Bethesda, MD, Publication No.97-4051, April 1997.
19. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997; 10: 646-51.
20. Crapo RO, Hankinson JL, Irvin C. Standardization of spirometry. Am J Respir Crit Care Med 1995; 152:1107-36.
21. Narayanan S, Edelman JM, Berger ML, Markson LE. Asthma control and patient satisfaction among early pediatric users of montelukast. J Asthma 2002; 39:757-65.
22. Pizzichini E, Leff JA, Reiss TF et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J 1999; 14:12-8.
23. Tohda Y, Nakahara H, Kubo H, Haraguchi R, Fukuoka M, Nakajima S. Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma. Clin Exp Allergy 1999; 29:1532-6.
24. Lin CC, Lin CY, Liaw SF, Chen A. Pulmonary function changes and immunomodulation of cytokine expression by zafirlukast after sensitization and allergen challenge in brown Norway rats. Clin Exp Allergy 2002; 32:960-6.
25. Stelmach I, Jerzyńska J, Kuna P. A randomised, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum ECP, s1L-2R, IL-4, and slCAM-1 in children with asthma. J Allergy Clin Immunol 2002; 109:11-7.
26. Takanashi S, Hasegawa Y, Kanehira Y, Yamamoto K, Fujimoto K, Okamura K. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J 1999; 14:309-14.
27. Wosinska-Becler K, Plewako H, Hakansson L, Rak S. Cytokine production in peripheral blood cells during and outside the pollen season in birch-allergic patients and non-allergic controls. Clin Exp Allergy 2004; 34:123-30.
28. Eum SY, Maghni K, Hamid Q, Campbell H, Eidelman DH, Martin JG. Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse. Am J Respir Cell Mol Biol 2003; 28:25-32.
29. Knorr B, Matz J, Bernstein A et al. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. JAMA 1998; 279:1181-6.
30. Moverare R, Elfman L, Stalenheim G, Bjornsson E. Study of the Th1/Th2 balance, including IL-10 production, in cultures of peripheral blood mononuclear cells from birch-pollen-allergic patients. Allergy 2000; 55:171-5.
31. Rudin A, Macaubas C, Wee C, Holt BJ, Slya PD, Holt PG. "Bystander0 amplification of PBMC cytokine responses to seasonal allergen in polysensitized atopic children. Allergy 2001; 56:1042-8.